High cholesterol diet effects on ischemia-reperfusion injury of the heart. 2012

Verónica D'Annunzio, and Martín Donato, and Bruno Buchholz, and Virginia Pérez, and Verónica Miksztowicz, and Gabriela Berg, and Ricardo J Gelpi
Institute of Cardiovascular Physiopathology, Department of Pathology, Faculty of Medicine, University of Buenos Aires, Argentina.

Ischemic heart disease is the leading cause of morbi-mortality in developed countries. Both ischemia-reperfusion injury and mechanisms of cardioprotection have been studied for more than 50 years. It is known that the physiopathological mechanism of myocardial ischemia involves several factors that are closely related to its development, of which hypercholesterolemia is one of the main ones. Therefore, the objective of this review was to elucidate the effects of a high-cholesterol diet on normal ventricular function and ischemia-reperfusion injury associated phenomenon such as post-ischemic ventricular dysfunction (stunned myocardium). Although there exist many studies considering several aspects of this physiopathological entity, the majority were carried out on normal animals. Thus, experiments carried out on hypercholesterolemic models are controversial, in particular those evaluating different mechanisms of cardioprotection such as ischemic preconditioning and postconditioning, and cardioprotection granted by drugs such as statins, which apart from exerting a lipid-lowering effect, exert pleiotropic effects providing cardioprotection against ischemia-reperfusion injury. These controversial results concerning the mechanisms of cardioprotection vary according to quality, composition, and time of administration of the high-cholesterol diet, as well as the species used in each experiment. Thus, to compare the results it is necessary to take all of these variables into account, since they can change the obtained results.

UI MeSH Term Description Entries
D002791 Cholesterol, Dietary Cholesterol present in food, especially in animal products. Dietary Cholesterol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D015428 Myocardial Reperfusion Injury Damage to the MYOCARDIUM resulting from MYOCARDIAL REPERFUSION (restoration of blood flow to ischemic areas of the HEART.) Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm. Reperfusion Injury, Myocardial,Injury, Myocardial Reperfusion,Myocardial Ischemic Reperfusion Injury,Injuries, Myocardial Reperfusion,Myocardial Reperfusion Injuries,Reperfusion Injuries, Myocardial
D016276 Ventricular Function The hemodynamic and electrophysiological action of the HEART VENTRICLES. Function, Ventricular,Functions, Ventricular,Ventricular Functions
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D057775 Ischemic Postconditioning The application of repeated, brief periods of vascular occlusion at the onset of REPERFUSION to reduce REPERFUSION INJURY that follows a prolonged ischemic event. The techniques are similar to ISCHEMIC PRECONDITIONING but the time of application is after the ischemic event instead of before. Ischemic Post-Conditioning,Ischemic Post Conditioning,Post-Conditioning, Ischemic,Postconditioning, Ischemic
D059305 Diet, High-Fat Consumption of excessive DIETARY FATS. Diet, High Fat,Diets, High Fat,Diets, High-Fat,High Fat Diet,High Fat Diets,High-Fat Diet,High-Fat Diets
D019157 Ischemic Preconditioning, Myocardial Exposure of myocardial tissue to brief, repeated periods of vascular occlusion in order to render the myocardium resistant to the deleterious effects of ISCHEMIA or REPERFUSION. The period of pre-exposure and the number of times the tissue is exposed to ischemia and reperfusion vary, the average being 3 to 5 minutes. Myocardial Preconditioning,Myocardial Ischemic Preconditioning,Preconditioning, Myocardial,Preconditioning, Myocardial Ischemic

Related Publications

Verónica D'Annunzio, and Martín Donato, and Bruno Buchholz, and Virginia Pérez, and Verónica Miksztowicz, and Gabriela Berg, and Ricardo J Gelpi
July 2008, Circulation journal : official journal of the Japanese Circulation Society,
Verónica D'Annunzio, and Martín Donato, and Bruno Buchholz, and Virginia Pérez, and Verónica Miksztowicz, and Gabriela Berg, and Ricardo J Gelpi
January 2001, Cardiovascular drugs and therapy,
Verónica D'Annunzio, and Martín Donato, and Bruno Buchholz, and Virginia Pérez, and Verónica Miksztowicz, and Gabriela Berg, and Ricardo J Gelpi
July 1997, Nihon Jinzo Gakkai shi,
Verónica D'Annunzio, and Martín Donato, and Bruno Buchholz, and Virginia Pérez, and Verónica Miksztowicz, and Gabriela Berg, and Ricardo J Gelpi
February 2004, Journal of cardiovascular pharmacology,
Verónica D'Annunzio, and Martín Donato, and Bruno Buchholz, and Virginia Pérez, and Verónica Miksztowicz, and Gabriela Berg, and Ricardo J Gelpi
August 1995, Shock (Augusta, Ga.),
Verónica D'Annunzio, and Martín Donato, and Bruno Buchholz, and Virginia Pérez, and Verónica Miksztowicz, and Gabriela Berg, and Ricardo J Gelpi
January 2015, European review for medical and pharmacological sciences,
Verónica D'Annunzio, and Martín Donato, and Bruno Buchholz, and Virginia Pérez, and Verónica Miksztowicz, and Gabriela Berg, and Ricardo J Gelpi
February 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
Verónica D'Annunzio, and Martín Donato, and Bruno Buchholz, and Virginia Pérez, and Verónica Miksztowicz, and Gabriela Berg, and Ricardo J Gelpi
June 2012, Cardiovascular drugs and therapy,
Verónica D'Annunzio, and Martín Donato, and Bruno Buchholz, and Virginia Pérez, and Verónica Miksztowicz, and Gabriela Berg, and Ricardo J Gelpi
February 2001, Coronary artery disease,
Verónica D'Annunzio, and Martín Donato, and Bruno Buchholz, and Virginia Pérez, and Verónica Miksztowicz, and Gabriela Berg, and Ricardo J Gelpi
November 2023, Heliyon,
Copied contents to your clipboard!